Fever News and Research

RSS

Researchers make breakthrough in finding a vaccine against horse disease strangle

A research group at the Department of Microbiology, Swedish University of Agricultural Sciences (SLU) in Uppsala, Sweden has - in collaboration with J-I Flock's research group at the Karolinska Institutet medical university in Stockholm, the pharmacological company Intervacc AB, Stockholm and the Animal Health Trust in the UK - after many years of research made a breakthrough in finding a vaccine against the horse disease strangle.

7 Oct 2009

Inviragen, SingVax merge their complementary vaccine pipelines

Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies.

6 Oct 2009

News outlets examines health impact of disasters in Indonesia, Samoa, Philippines

In Indonesia, "[r]escue workers called off the search Monday for life under the rubble left by a massive earthquake, focusing instead on bringing aid to survivors," the Agence France-Presse reports. "The United Nations has said at least 1,100 people were killed in the disaster, but estimates of the final toll range up to 5,000. The official toll stood at 650 dead and 672 missing, according to the health ministry," the news service writes (Belford, 10/5).

6 Oct 2009

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.

5 Oct 2009

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Cumberland Pharmaceuticals Inc. announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.

5 Oct 2009

Surgical masks nearly as effective as N95 respirators in protecting health care workers against influenza

Surgical masks appear to be no worse than, and nearly as effective as N95 respirators in preventing influenza in health care workers, according to a study released early online today by JAMA. The study was posted online ahead of print because of its public health implications. It will be published in the November 4 issue of JAMA.

3 Oct 2009

Bacteria could be used to control mosquitoes, prevent disease, study says

New findings, published in the journal Science, about the bacteria Wolbachia could be used to control mosquito populations and prevent malaria, dengue fever and other mosquito-borne diseases, Discovery News reports.

2 Oct 2009

Study shows students do not follow proper hygiene routines

Thousands of bacteria lurk in college dormitories, but students are not following proper hygiene routines to help protect themselves from serious illness, according to a study released today from the Simmons College Center for Hygiene and Health in Home and Community, sponsored by an educational grant from LYSOL® brand products.

1 Oct 2009

Fetal exposure to H1N1 flu can increase risk of heart disease

People exposed to a H1NI strain of influenza A while in utero were significantly more likely to have cardiovascular disease later in life, reveals a new study to be published in Journal of Developmental Origins of Health and Disease on Oct. 1.

1 Oct 2009

Also in global health news: Tanzania's development initiatives; disease surveillance in West Africa; water, sanitation in Kenya, Malawi; doctor fights Lassa fever

House Speaker Nancy Pelosi, D-Calif., on Tuesday commended Tanazanian President Jakaya Kikwete on the country's utilization of U.S. aid money and vowed her support for the country's future development projects, during a meeting in Washington, D.C., the Zimbabwean reports. "Pelosi hailed President Kikwete and his government for the commitment demonstrated by the campaigns against HIV/AIDS, malaria and TB and implementation of MCC programmes," the newspaper writes (Kulekana, 9/30).

1 Oct 2009

Deal between GSK, Brazil to strengthen country's pharmaceutical R&D

GlaxoSmithKline (GSK) Chief Executive Andrew Witty on Friday announced Brazil has agreed to buy roughly $2.2 billion of the company's vaccine for pneumococcal disease, Synflorix, for a period of at least eight years, in exchange for a technology transfer, eventually allowing Brazil to manufacture the vaccine itself, the Wall Street Journal reports.

29 Sep 2009

Flu shots available at Concentra Urgent Care locations

The flu season is in full swing, and health officials predict this year’s outbreak of seasonal influenza to be stronger than usual. To help protect against this highly contagious illness, Concentra is offering seasonal flu vaccines at more than 300 medical centers across the country.

29 Sep 2009

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).

26 Sep 2009

EMS provides free resources for protection against swine flu

Emergency Management & Safety Solutions (EMS), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help people prepare for, prevent transmission of and take care of the ill to survive this wave of this year’s H1N1 flu pandemic. Today, over 180 countries have experienced the H1N1 virus outbreak and at least 3,486 people have died – including 1,000 Americans.

26 Sep 2009

Folotyn approved for the treatment of Peripheral T-Cell Lymphoma

The U.S. Food and Drug Administration has approved Folotyn (pralatrexate), the first treatment for a form of cancer known as Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.

25 Sep 2009

Phase 1b interim clinical trial results of IMO-2055, Tarceva and Avast combination announced

Idera Pharmaceuticals (Nasdaq: IDRA) today presented interim data from a phase 1b, single arm clinical trial evaluating IMO-2055, an agonist of Toll-like Receptor (TLR) 9, in combination with Tarceva® and Avastin® in patients with non-small cell lung cancer (NSCLC).

23 Sep 2009

Children’s Hospital offers tips on H1N1 and seasonal flu

With the early onset of flu season coinciding with the start of school this year, parents are concerned about the flu. Experts from The Children’s Hospital in Denver, Colo., offer a pediatric perspective on all types of flu, including H1N1, also known as swine flu.

23 Sep 2009

Bacterium responsible for outbreaks identified

University of Central Florida Microbiology Professor Keith Ireton has uncovered a previously unknown mechanism that plays an important role in the spread of a deadly food-borne bacterium.

22 Sep 2009

Study reveals that daily commuting may lead to mosquito-borne diseases

University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.

21 Sep 2009

Fever News and Research

Researchers make breakthrough in finding a vaccine against horse disease strangle

Inviragen, SingVax merge their complementary vaccine pipelines

News outlets examines health impact of disasters in Indonesia, Samoa, Philippines

MSF calls on drug companies to pool HIV patents

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Surgical masks nearly as effective as N95 respirators in protecting health care workers against influenza

Bacteria could be used to control mosquitoes, prevent disease, study says

Study shows students do not follow proper hygiene routines

Fetal exposure to H1N1 flu can increase risk of heart disease

Also in global health news: Tanzania's development initiatives; disease surveillance in West Africa; water, sanitation in Kenya, Malawi; doctor fights Lassa fever

Deal between GSK, Brazil to strengthen country's pharmaceutical R&D

Flu shots available at Concentra Urgent Care locations

Morphotek announces preliminary data from Phase II trial of farletuzumab

EMS provides free resources for protection against swine flu

Folotyn approved for the treatment of Peripheral T-Cell Lymphoma

Phase 1b interim clinical trial results of IMO-2055, Tarceva and Avast combination announced

Children’s Hospital offers tips on H1N1 and seasonal flu

Bacterium responsible for outbreaks identified

Study reveals that daily commuting may lead to mosquito-borne diseases

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News